Form 4: Alnylam CEO Yvonne Greenstreet Reports Stock Sales to Cover Tax Obligations
SEC Form 4 Filing
Alnylam Pharmaceuticals CEO Yvonne Greenstreet sold shares of common stock on February 28, 2025, to cover tax obligations related to vesting restricted stock units.
Summary
- Yvonne Greenstreet, CEO of Alnylam Pharmaceuticals, reported the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.
- On February 27, 2025, 5,921 restricted stock units vested.
- On February 28, 2025, a total of 2,890 shares were sold at prices ranging from $236.51 to $244.32.
- These sales were executed to cover minimum statutory tax withholding obligations.
- Following these transactions, Greenstreet directly owns 84,547 shares of Alnylam common stock and indirectly owns 407 shares through a managed account.
- She also owns 5,921 derivative securities in the form of restricted stock units.
Sentiment
Score: 5
Explanation: The document reflects routine transactions related to executive compensation and tax obligations, with no indication of positive or negative sentiment.
Industry Context
Executive stock sales are a common occurrence, particularly to cover tax obligations upon the vesting of stock awards. These transactions are closely monitored by investors for insights into management's perspective on the company's value, although sales for tax purposes are generally viewed as routine.
Comparison to Industry Standards
- Executive compensation packages often include restricted stock units that vest over time.
- The sale of shares to cover tax obligations is a standard practice among executives at publicly traded companies.
- Similar transactions are regularly reported by executives at comparable pharmaceutical companies.
Stakeholder Impact
- The stock sales may have a minor, temporary impact on the stock price.
- The transactions do not directly affect employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 02/27/2023 | Reporting person was granted 17,763 restricted stock units that vest ratably on each of the first, second and third anniversaries of the Grant Date. |
| 02/27/2025 | Restricted stock units vested; transaction date for derivative security exercise. |
| 02/28/2025 | Date of common stock sales. |
| 03/03/2025 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.